Literature DB >> 1166316

Parathyroid hormone and 25-hydroxy vitamin D3: synergistic and antagonistic effects on renal phosphate transport.

J B Puschett, W S Beck.   

Abstract

The effect on phosphate excretion of graded doses of parathyroid hormone (PTH) and the biologically active vitamin D3 metabolite, 25-hydroxycholecalciferol (25-HCC), administered singly and in combination, were studied in the nonexpanded, vitamin D-depleted thyroparathyroidectomized rat. Infusion of 1 unit of 25-HCC per hour for 6 hours induced an antiphosphaturia only when administered with 0.2 units of PTH per hour, while neither agent alone changed phosphate excretion. A dose of 2.0 units of PTH per hour did not cause phosphaturia unless given with 1 unit of 25-HCC per hour. In pharmacologic dosage (5 units per hour), PTH produced phosphaturia in the absence of the metabolite.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1166316     DOI: 10.1126/science.1166316

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Vitamin D metabolism and expression in rats fed on low-calcium and low-phosphorus diets.

Authors:  S Edelstein; D Noff; L Sinai; A Harell; J B Puschett; E E Golub; F Bronner
Journal:  Biochem J       Date:  1978-02-15       Impact factor: 3.857

2.  The role of phosphate in the action of vitamin D on the intestine.

Authors:  S J Birge; R Miller
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

Review 3.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

4.  Interactions between vitamin D deficiency and phosphorus depletion in the rat.

Authors:  N Brautbar; M W Walling; J W Coburn
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

5.  Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.

Authors:  E Short; R C Morris; A Sebastian; M Spencer
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.